نتایج جستجو برای: core e1e2

تعداد نتایج: 215195  

Journal: :iranian journal of biotechnology 2015
seyyedeh masumeh mirnurollahi azam bolhassani shiva irani noushin davoudi

background: hepatitis c virus (hcv) is a main public health problem causing chronic liver infection and subsequently liver cirrhosis and lethal hepatocellular carcinoma (hcc). vaccination based on hcv capsid proteins has attracted a special interest for prevention of viral infections. the core protein is a basic and evolutionary most conserved protein, which regulates the cellular processes rel...

Background: Hepatitis C virus (HCV) is a main public health problem causing chronic liver infection and subsequently liver cirrhosis and lethal hepatocellular carcinoma (HCC). Vaccination based on HCV capsid proteins has attracted a special interest for prevention of viral infections. The core protein is a basic and evolutionary most conserved protein, which regulates the cellular processes rel...

Journal: :Intervirology 2011
Ndiémé Ndongo Subjini Selliah Pascale Berthillon Valérie-Ann Raymond Christian Trépo Marc Bilodeau Marie-Anne Petit

OBJECTIVE To determine whether liver-derived hepatitis C RNA-containing particles express the E1E2 discontinuous antigenic determinant defined by unique monoclonal antibody (mAb) D32.10 which recognizes three highly conserved segments in E1 (aa297-306) and E2 (aa480-494 and aa613-621) envelope glycoproteins. METHODS Human hepatocytes were isolated from HCV-infected cirrhotic explanted livers....

Journal: :journal of paramedical sciences 0
masoumeh mirnurollahi department of biology, science and research branch, islamic azad university, tehran, iran shiva irani department of biology, science and research branch, islamic azad university, tehran, iran azam bolhassani department of hepatitis and aids, pasteur institute of iran, tehran, iran

hepatitis c virus (hcv) is an important agent causing chronic liver infection, which often leads to liver cirrhosis and lethal hepatocellular carcinoma (hcc). at present, there is no effective hcv vaccine for prevention of hepatic disease and the standard treatment is neither economical nor fully effective in all the patients. however, vaccination based on structural and nonstructural proteins ...

Journal: :Iranian journal of biotechnology 2015
Seyyedeh Masumeh Mirnurollahi Azam Bolhassani Shiva Irani Noushin Davoudi

BACKGROUND Hepatitis C virus (HCV) is a main public health problem causing chronic liver infection and subsequently liver cirrhosis and lethal hepatocellular carcinoma (HCC). Vaccination based on HCV capsid proteins has attracted a special interest for prevention of viral infections. The core protein is a basic and evolutionary most conserved protein, which regulates the cellular processes rela...

2017
Radhika Gopal Kelli Jackson Netanel Tzarum Leopold Kong Andrew Ettenger Johnathan Guest Jennifer M Pfaff Trevor Barnes Andrew Honda Erick Giang Edgar Davidson Ian A Wilson Benjamin J Doranz Mansun Law

The hepatitis C virus (HCV) envelope glycoproteins E1 and E2 form a non-covalently linked heterodimer on the viral surface that mediates viral entry. E1, E2 and the heterodimer complex E1E2 are candidate vaccine antigens, but are technically challenging to study because of difficulties in producing natively folded proteins by standard protein expression and purification methods. To better compr...

Journal: :The Journal of biological chemistry 2006
Virginie Sandrin François-Loïc Cosset

Retroviral Gag and Env glycoproteins (GPs) are expressed from distinct cellular areas and need to encounter to interact and assemble infectious particles. Retroviral particles may also incorporate GPs derived from other enveloped viruses via active or passive mechanisms, a process known as "pseudotyping." To further understand the mechanisms of pseudotyping, we have investigated the capacity of...

Journal: :Journal of virology 2017
Michael Logan John Law Jason Alexander Ji-Xhin Wong Darren Hockman Amir Landi Chao Chen Kevin Crawford Juthika Kundu Lesley Baldwin Janelle Johnson Anita Dahiya Gerald LaChance Joseph Marcotrigiano Mansun Law Steven Foung Lorne Tyrrell Michael Houghton

A recombinant strain HCV1 (hepatitis C virus [HCV] genotype 1a) gpE1/gpE2 (E1E2) vaccine candidate was previously shown by our group to protect chimpanzees and generate broad cross-neutralizing antibodies in animals and humans. In addition, recent independent studies have highlighted the importance of conserved neutralizing epitopes in HCV vaccine development that map to antigenic clusters in E...

Journal: :Journal of virology 2014
Tinashe B Ruwona Erick Giang Travis Nieusma Mansun Law

UNLABELLED The hepatitis C virus (HCV) envelope glycoprotein E1E2 complex is a candidate vaccine antigen. Previous immunization studies of E1E2 have yielded various results on its ability to induce virus-neutralizing antibodies in animal models and humans. The murine model has become a vital tool for HCV research owing to the development of humanized mice susceptible to HCV infection. In this s...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید